Brief: Taisho Pharmaceutical Completes Procedures For Acquisition Of UPSA SAS
July 2 (Reuters) - Japan's Taisho Pharmaceutical 4581.T :
* COMPLETES PROCEDURES FOR ACQUISITION OF UPSA SAS
Source text: urn:newsml:reuters.com:*:nTSSB71cec
Further company coverage: 4581.T
(Reporting By Chris Gallagher)
((chris.gallagher@thomsonreuters.com;))
Recent news on Taisho Pharmaceutical Holdings Co
See all newsBrief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Squeeze Out Price If Taisho Disagrees With Their Demand - Nikkei
Brief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Tender Offer Price If Taisho Disagrees Their Demand - Nikkei
Activist fund Oasis says it may take legal action over Taisho's management buyout
Brief: Curi RMB Capital Opposes Taisho Pharmaceutical HD's Management Buyout
To Retire Treasury Shares Worth 3.65% Of Outstanding Stock On April 10